Hua Chen

4.1k total citations
189 papers, 3.1k citations indexed

About

Hua Chen is a scholar working on Psychiatry and Mental health, Cardiology and Cardiovascular Medicine and Geriatrics and Gerontology. According to data from OpenAlex, Hua Chen has authored 189 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Psychiatry and Mental health, 32 papers in Cardiology and Cardiovascular Medicine and 28 papers in Geriatrics and Gerontology. Recurrent topics in Hua Chen's work include Schizophrenia research and treatment (32 papers), Pharmaceutical Practices and Patient Outcomes (28 papers) and Dementia and Cognitive Impairment Research (23 papers). Hua Chen is often cited by papers focused on Schizophrenia research and treatment (32 papers), Pharmaceutical Practices and Patient Outcomes (28 papers) and Dementia and Cognitive Impairment Research (23 papers). Hua Chen collaborates with scholars based in United States, China and Australia. Hua Chen's co-authors include Rajender R. Aparasu, Michael L. Johnson, Pravin Kamble, Satabdi Chatterjee, Jeffrey T. Sherer, Qun Chen, Michael Chopp, Ryan M. Carnahan, Holly M. Holmes and Bradley C. Martin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Management Science.

In The Last Decade

Hua Chen

176 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hua Chen United States 31 803 580 429 346 306 189 3.1k
Richard A. Hansen United States 39 1.2k 1.5× 345 0.6× 659 1.5× 423 1.2× 398 1.3× 216 6.3k
Mitchell Levine Canada 33 438 0.5× 293 0.5× 408 1.0× 549 1.6× 247 0.8× 161 4.2k
Ju‐Young Shin South Korea 27 399 0.5× 279 0.5× 303 0.7× 309 0.9× 535 1.7× 303 3.0k
Kari Furu Norway 41 855 1.1× 468 0.8× 270 0.6× 459 1.3× 581 1.9× 157 5.0k
Saad Shakir United Kingdom 33 649 0.8× 452 0.8× 455 1.1× 509 1.5× 258 0.8× 147 4.9k
Denise M. Boudreau United States 41 521 0.6× 544 0.9× 400 0.9× 564 1.6× 733 2.4× 125 6.2k
Jean‐Pierre Grégoire Canada 40 617 0.8× 753 1.3× 641 1.5× 684 2.0× 796 2.6× 238 7.0k
Andrew D. Shore United States 33 255 0.3× 378 0.7× 264 0.6× 376 1.1× 288 0.9× 79 4.0k
Lolkje T.W. de Jong‐van den Berg Netherlands 37 738 0.9× 405 0.7× 288 0.7× 282 0.8× 312 1.0× 142 4.2k
Susan Shetterly United States 35 420 0.5× 276 0.5× 431 1.0× 817 2.4× 534 1.7× 94 4.5k

Countries citing papers authored by Hua Chen

Since Specialization
Citations

This map shows the geographic impact of Hua Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hua Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hua Chen more than expected).

Fields of papers citing papers by Hua Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hua Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hua Chen. The network helps show where Hua Chen may publish in the future.

Co-authorship network of co-authors of Hua Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Hua Chen. A scholar is included among the top collaborators of Hua Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hua Chen. Hua Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goyal, RK, Sean D. Candrilli, Susan Abughosh, et al.. (2024). Social Determinants of Health and Other Predictors in Initiation of Treatment with CDK4/6 Inhibitors for HR+/HER2− Metastatic Breast Cancer. Cancers. 16(12). 2168–2168. 1 indexed citations
2.
Liu, Chenang, et al.. (2023). A self-inspected adaptive SMOTE algorithm (SASMOTE) for highly imbalanced data classification in healthcare. BioData Mining. 16(1). 15–15. 43 indexed citations
3.
Huang, Yinan, Sandeep K. Agarwal, Hua Chen, et al.. (2023). Real-world Comparative Effectiveness of Methotrexate-based Combinations for Rheumatoid Arthritis: A Retrospective Cohort Study. Clinical Therapeutics. 45(9). e177–e186. 2 indexed citations
4.
Huang, Yinan, Sandeep K. Agarwal, Satabdi Chatterjee, et al.. (2023). Risk of incident cardiovascular events with disease-modifying anti-rheumatic drugs among adults with rheumatoid arthritis: a nested case-control study. Clinical Rheumatology. 43(1). 103–116. 2 indexed citations
5.
6.
Rege, Sanika, Ryan M. Carnahan, Michael L. Johnson, et al.. (2021). Antipsychotic Initiation Among Older Dementia Patients Using Cholinesterase Inhibitors: A National Retrospective Cohort Study. Drugs & Aging. 38(6). 493–502. 3 indexed citations
7.
Hutton, George J., et al.. (2021). Comparative treatment effectiveness of oral fingolimod and conventional injectable disease‐modifying agents in multiple sclerosis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 41(5). 440–450. 2 indexed citations
8.
Chatterjee, Satabdi, et al.. (2021). Risk of overactive bladder associated with cholinesterase inhibitors in dementia. Journal of the American Geriatrics Society. 70(3). 820–830. 3 indexed citations
9.
Chen, Jiabin, et al.. (2020). Sarcomatoid carcinoma of the gallbladder: a case report. Journal of International Medical Research. 48(6). 1220734835–1220734835. 10 indexed citations
10.
Holmes, Holly M., et al.. (2020). <p>Use of Atypical Antipsychotics in Long-Term Care Residents with Parkinson’s Disease and Comorbid Depression</p>. Drug Healthcare and Patient Safety. Volume 12. 23–30. 8 indexed citations
11.
Holmes, Holly M., et al.. (2020). Risk of Mortality Associated with Non-selective Antimuscarinic medications in Older Adults with Dementia: a Retrospective Study. Journal of General Internal Medicine. 35(7). 2084–2093. 11 indexed citations
12.
Holmes, Holly M., et al.. (2020). Comparative risk of adverse outcomes associated with nonselective and selective antimuscarinic medications in older adults with dementia and overactive bladder. International Journal of Geriatric Psychiatry. 36(5). 684–696. 6 indexed citations
13.
Liao, Yi & Hua Chen. (2020). Effects of complement dysfunction on diabetic retinopathy. Zhonghua shiyan yanke zazhi. 38(1). 68–72. 1 indexed citations
14.
15.
Mgbere, Osaro, et al.. (2017). Modeling ecodevelopmental context of sexually transmitted disease/HIV risk and protective behaviors among African-American adolescents. HIV/AIDS - Research and Palliative Care. Volume 9. 119–135. 7 indexed citations
16.
Li, Jian, et al.. (2011). The role of von Willebrand factor and ADAMTS13 in the no-reflow phenomenon: after primary percutaneous coronary intervention.. PubMed. 38(5). 516–22. 14 indexed citations
17.
Li, Weihong, et al.. (2010). Efficacy comparison of cervical cancer screening system and liquid based cytology test in detection of cervical lesions. 16(9). 1129–1134. 2 indexed citations
18.
Wei, Junqiang, Boxun Zhang, Hua Chen, Peifu Tang, & Yan Wang. (2010). Effect of calcium sulfate on gene expression in differentiation of human BMSCs into osteoblasts. Zhonghua shiyan waike zazhi. 27(11). 1589–1591.
19.
Chen, Hua, Xiaobiao Xu, & Jiwu Zeng. (2005). Construction of the AFLP Analysis System for Actinidia Genome. Xibei zhiwu xuebao.
20.
Chen, Hua. (2000). Weight Estimation and Test of Significance about Combination Forecasting. Yunchou yu guanli.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard A. Hansen Breakdown of academic impact, for papers by Mitchell Levine Breakdown of academic impact, for papers by Ju‐Young Shin Breakdown of academic impact, for papers by Kari Furu Breakdown of academic impact, for papers by Saad Shakir Breakdown of academic impact, for papers by Denise M. Boudreau Breakdown of academic impact, for papers by Jean‐Pierre Grégoire Breakdown of academic impact, for papers by Andrew D. Shore Breakdown of academic impact, for papers by Lolkje T.W. de Jong‐van den Berg Breakdown of academic impact, for papers by Susan Shetterly
Rankless by CCL
2026